Search results
Potential link found between Merck antiviral and mutated COVID strains
KREX articles via Yahoo News· 7 months agoMolnupiravir, known commercially as Lagevrio, is one of two COVID-19 antivirals authorized for...
At All-Time Highs, Merck's Stock Is Nearing a Cliff
GuruFocus.com via Yahoo Finance· 1 year agoThroughout the beginning of the Covid-19 pandemic, pharmaceutical companies were mostly focused on the availability and effectiveness of vaccines....
Stock Market Pares Losses But Still Closes In The Red And Posts Worst Year Since 2008
Investor's Business Daily· 1 year agoThe stock market pared losses late Friday but still closed in the red, adding to a painful year for...
Merck, Ridgeback Announce New Molnupiravir Data From Late-Stage COVID-19 Study
Benzinga via Yahoo Finance· 2 years agoMerck & Co Inc (NYSE: MRK) and Ridgeback Biotherapeutics announced that the Annals of Internal...
7 Quality Dividend Stocks to Buy on the Dip
InvestorPlace via Yahoo Finance· 2 years agoIn the current market evironment, investors could find solid ground with this dividend stocks to buy. Merck (MRK): Robust results across its core...
Merck and Block have been highlighted as Zacks Bull and Bear of the Day
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – July 18, 2022 – Zacks Equity Research shares Merck & Co. MRK as...
Stock Market Adds To Pain Of Biggest Losses In 14 Years
Investor's Business Daily· 1 year agoThe major stock market held morning losses, down in the last hour and off the lows of the day....
7 Stocks to Buy and Hold Forever in This Bear Market
InvestorPlace via Yahoo Finance· 2 years agoBearish stock market conditions are creating extreme fear for investors. Many investors who are low on cash and highly exposed to stocks feel demoralized...
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks via Yahoo Finance· 11 months agoMerck MRK boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor Keytruda...
UK Study Shows Merck's COVID-19 Antiviral Pill Did Not Cut Hospitalization Risk
Benzinga via Yahoo Finance· 2 years agoMerck & Co Inc (NYSE: MRK) and Ridgeback Biotherapeutics announced data from two real-world evidence...